Overview: Vitamin D 1,25-Dihydroxy TestIntroduction: The Vitamin D 1,25-Dihydroxy Test measures 1,25-dihydroxy vitamin D to diagnose bone disorders, causing weakness. Aligned with 2023 Endocrine Society guidelines, it uses biochemical methods for high specificity, supporting metabolic screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected bone disorders.
Other Names: 1,25-Dihydroxy Vitamin D Assay, Calcitriol Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: 1,25-Dihydroxy vitamin D testing began in the 1970s with bone metabolism research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures 1,25-dihydroxy vitamin D to diagnose bone disorders, guides treatment, and evaluates patients with weakness.
Test Parameters: 1. 1,25-Dihydroxy Vitamin D Level
Pretest Condition: Fasting for 10-12 hours required. Collect serum or plasma. Report history of weakness or bone disorders.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document weakness, bone pain, or history of bone disorders. Include current medications, especially vitamin D supplements.
Consent: Written consent required, detailing the tests purpose, bone disorder implications, and risks of sample collection.
Procedural Considerations: Uses radioimmunoassay or LC-MS to measure 1,25-dihydroxy vitamin D levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for bone disorder diagnosis.
Factors Affecting Result Accuracy: Improper fasting or sample hemolysis can affect results. Renal function may alter levels.
Clinical Significance: Abnormal 1,25-dihydroxy vitamin D levels confirm bone disorders, guiding supplementation or therapy. Normal levels may require 25-hydroxy vitamin D testing.
Specialist Consultation: Consult an endocrinologist or orthopedist for result interpretation and treatment planning.
Additional Supporting Tests: 25-Hydroxy vitamin D, calcium levels, or bone density scan to confirm bone disorder diagnosis.
Test Limitations: Non-specific for disorder cause; clinical correlation is needed. Sample quality affects sensitivity.
References: Endocrine Society Vitamin D Guidelines, 2023; Journal of Clinical Endocrinology, Holick MF, 2022.
